Activated B lymphocytes and tumor cell lysate as an effective cellular cancer vaccine

Nanoparticle-Mediated Drug Delivery for Treatment of Ischemic Heart Disease

(2020) Chengming Fan et al.   Frontiers in Bioengineering and Biotechnology

Turning the corner on therapeutic cancer vaccines

(2019) Robert E. Hollingsworth et al.   npj Vaccines

B Cell Responses: Cell Interaction Dynamics and Decisions

(2019) Jason G. Cyster et al.   CELL

Cancer DNA vaccines: current preclinical and clinical developments and future perspectives

(2019) Alessandra Lopes et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Advances in cancer immunotherapy 2019 – latest trends

(2019) Stephan Kruger et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Harnessing innate immunity in cancer therapy

(2019) Olivier Demaria et al.   NATURE

The immune landscape and response to immune checkpoint blockade therapy in lymphoma

(2019) Justin Kline et al.   BLOOD

A Believer’s Overview of Cancer Immunosurveillance and Immunotherapy

(2018) Olivera J. Finn   JOURNAL OF IMMUNOLOGY

B lymphocytes can be activated to act as antigen presenting cells to promote anti-tumor responses

(2018) Renata Ariza Marques Rossetti et al.   PLoS One

Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion

(2018) Flávia Castro et al.   Frontiers in Immunology

CD11a and CD49d enhance the detection of antigen-specific T cells following human vaccination

(2017) Allison F. Christiaansen et al.   VACCINE

The Other Function: Class II-Restricted Antigen Presentation by B Cells

(2017) Lital N. Adler et al.   Frontiers in Immunology

The Emerging Role of B Cells in Tumor Immunity

(2016) Peiling Tsou et al.   CANCER RESEARCH

B lymphocytes as direct antigen-presenting cells for anti-tumor DNA vaccines

(2016) Viswa Teja Colluru et al.   Oncotarget

Preclinical Mouse Cancer Models: A Maze of Opportunities and Challenges

(2015) Chi-Ping Day et al.   CELL

The adaptor protein TRAF3 inhibits interleukin-6 receptor signaling in B cells to limit plasma cell development

(2015) Wai W. Lin et al.   Science Signaling

The adaptor protein TRAF3 inhibits interleukin-6 receptor signaling in B cells to limit plasma cell development

(2015) Wai W. Lin et al.   Science Signaling

Polarizing T and B Cell Responses by APC-Targeted Subunit Vaccines

(2015) Gunnveig Grødeland et al.   Frontiers in Immunology

B Cells Are Critical to T-cell—Mediated Antitumor Immunity Induced by a Combined Immune-Stimulatory/Conditionally Cytotoxic Therapy for Glioblastoma

(2015) Marianela Candolfi et al.   NEOPLASIA

Dendritic-Cell-Based Therapeutic Cancer Vaccines

(2013) Karolina Palucka et al.   IMMUNITY

Soluble CD40 ligand-activated human peripheral B cells as surrogated antigen presenting cells: A preliminary approach for anti-HBV immunotherapy

(2011) Chao Wu et al.   Virology Journal

Harnessing Dendritic Cells for Tumor Antigen Presentation

(2011) Stefan Nierkens et al.   Cancers

Cutting Edge: Importance of IL-6 and Cooperation between Innate and Adaptive Immune Receptors in Cellular Vaccination with B Lymphocytes

(2009) T. J. Vanden Bush et al.   JOURNAL OF IMMUNOLOGY

The role of B lymphocytes as antigen-presenting cells

(2008) Xinjian Chen et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

CD40-activated B cells can be generated in high number and purity in cancer patients: analysis of immunogenicity and homing potential

(2008) E. Kondo et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY